What is the current Aneroid Sphygmomanometers market size?

The Aneroid Sphygmomanometers market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Aneroid Sphygmomanometers market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Aneroid Sphygmomanometers market?

Key drivers include rising healthcare costs and growing demand for accurate blood pressure monitoring devices.

What challenges does the Aneroid Sphygmomanometers market face?

Challenges include intense competition and rapidly evolving technology in the medical devices industry.

Which regions are the leaders in the Aneroid Sphygmomanometers market?

North America and Europe are the leading regions, accounting for over 60% of the market share.

Who are the top companies in the Aneroid Sphygmomanometers market?

Top companies include Omron, Hillrom, and GE Healthcare, offering a range of blood pressure monitoring devices.

What future opportunities exist in the Aneroid Sphygmomanometers market?

Future opportunities include emerging markets and the development of innovative, portable devices.

How will technology impact the Aneroid Sphygmomanometers market?

Advancements in digital technology will drive growth, with a focus on wireless and mobile health devices.

What is the current regulatory landscape for the Aneroid Sphygmomanometers market?

The market is regulated by stringent FDA and CE guidelines, ensuring device safety and efficacy.

What is the future outlook for the Aneroid Sphygmomanometers market?

The future outlook is positive, with increasing demand for accurate and reliable blood pressure monitoring devices.

How Big Is the Aneroid Sphygmomanometers Market? Size, Share & Forecast 2033

Aneroid Sphygmomanometers by Application (Hospitals, Clinics, Household), by Types (Wrist, Arm Type), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $7144.7 million

CAGR: 3.3%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $7144.7 million

CAGR: 3.3%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Aneroid Sphygmomanometers Market Size | CAGR 3.3% Forecast 2033

How Big Is the Aneroid Sphygmomanometers Market? Size, Share & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $7144.7 million

CAGR: 3.3%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $7144.7 million

CAGR: 3.3%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Aneroid Sphygmomanometers Market Overview

The Aneroid Sphygmomanometers market refers to the industry that produces and distributes manual blood pressure monitors. As a crucial component of the healthcare and medical devices sector, the Aneroid Sphygmomanometers market size is estimated to be around $1.3 billion. The growth outlook for this market is positive, driven by an increasing demand for accurate blood pressure monitoring and portable medical devices. The market forecast suggests a compound annual growth rate (CAGR) of 4.5% from 2026 to 2033, with the industry expansion expected to be driven by technology shifts, regulations, and consumer behavior.

Loading chart…

The largest region for the Aneroid Sphygmomanometers market is North America, accounting for over 30% of the global market share, while the fastest-growing region is Asia-Pacific, driven by an increasing demand for affordable healthcare solutions. Key forces shaping the industry include advances in technology, stringent regulations, and changing consumer behavior. As the market continues to evolve, manufacturers must adapt to these changes to remain competitive and capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	7.14 billion
Revenue forecast in 2033	12.46 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	A&D Medical; GE Healthcare; Omron; Philips; Microlife Corporation; Paul Hartmann AG; Suntech Medical; Welch Allyn; American Diagnostic; Beurer; Rudolf Riester GmbH; Terumo Corporation; Bosch + Sohn; Briggs Healthcare; Choicemmed; Citizen; W.A. Baum; Rossmax International
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Aneroid Sphygmomanometers market is poised for significant growth, driven by various factors that are shaping its dynamics. Understanding these market dynamics is crucial for stakeholders to navigate the landscape effectively and make informed decisions.

Growth Drivers2 items

Increasing demand for accurate blood pressure monitoring devices in both clinical and home settings is driving the Aneroid Sphygmomanometers market size, with a notable growth forecast anticipated over the next few years.

Advancements in technology, such as the integration of digital displays and improved durability, are enhancing the appeal of Aneroid Sphygmomanometers, thereby contributing to market expansion.

Restraints2 items

The Aneroid Sphygmomanometers market faces restraints due to the increasing preference for digital sphygmomanometers, which offer more convenience and ease of use, potentially limiting the growth of the Aneroid Sphygmomanometers market.

Stringent regulatory requirements and the need for frequent calibration of Aneroid Sphygmomanometers can also act as barriers to their adoption, affecting the overall market size.

Opportunities2 items

Emerging markets, particularly in developing economies, present significant opportunities for the Aneroid Sphygmomanometers market, driven by growing healthcare infrastructure and increasing awareness about blood pressure management.

The trend towards portable and compact medical devices opens up opportunities for innovative Aneroid Sphygmomanometer designs that are more patient-friendly and accessible, potentially boosting the growth forecast of the Aneroid Sphygmomanometers market.

Challenges2 items

The Aneroid Sphygmomanometers market must address the challenge of competition from alternative blood pressure monitoring technologies, which can impact market share and revenue.

Ensuring accuracy and reliability in Aneroid Sphygmomanometers while maintaining cost-effectiveness is a key challenge that manufacturers must overcome to sustain growth in the Aneroid Sphygmomanometers market size.

Market Segmentation

Loading chart…

The Aneroid Sphygmomanometers market can be segmented based on Application, which includes medical and clinical settings. This segmentation contributes to the overall Aneroid Sphygmomanometers market size by providing insights into the various uses of aneroid sphygmomanometers. Understanding the application segment is crucial for manufacturers to develop products that cater to specific needs, ultimately driving the growth of the Aneroid Sphygmomanometers segmentation market.

The Aneroid Sphygmomanometers market can also be segmented based on Types, which includes [object Object],[object Object] subtypes. This segmentation helps in identifying the different types of aneroid sphygmomanometers available in the market, such as manual and automatic devices. Analyzing the types segment is essential for market players to understand the competitive landscape and develop strategies to gain a competitive edge in the Aneroid Sphygmomanometers market taxonomy.

Aneroid Sphygmomanometers Segmentation Breakdown7 items

Application

Hospitals

Clinics

Household

Types

Wrist

Arm Type

Regional Insights

Loading chart…

The Aneroid Sphygmomanometers market growth is expected to vary across regions, with the largest region being Asia Pacific, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Latin America, driven by increasing adoption of aneroid sphygmomanometers in healthcare settings.

Key drivers for each region include: for North America, investments in healthcare infrastructure and a mature ecosystem; for Europe, policies supporting the use of aneroid sphygmomanometers and a high level of demographics awareness; for Asia Pacific, large demographics and increasing adoption of aneroid sphygmomanometers; for Latin America, growing investments in healthcare and improving infrastructure; and for Middle East & Africa, rising adoption of aneroid sphygmomanometers and expanding ecosystem maturity.

The regional forecast indicates that Asia Pacific will continue to dominate the market, driven by its large demographics and increasing adoption of aneroid sphygmomanometers. Latin America is expected to experience rapid growth, driven by investments in healthcare infrastructure and improving infrastructure.

Competitive Landscape

The Aneroid Sphygmomanometers market is moderately consolidated, driven by a mix of global players and local companies. The Aneroid Sphygmomanometers competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships, while local companies concentrate on pricing and distribution strengths.

Companies in this market employ various strategies, including M&A, partnerships, product launches, expansion, R&D, and localization, to differentiate themselves. However, they face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To stay competitive, companies must focus on technology, service model, channel strength, customization, and cost advantages.

A&D Medical: regional expansion

GE Healthcare: innovation pipeline

Omron: premium pricing

Philips: vertical integration

Microlife Corporation: local manufacturing

Paul Hartmann AG: OEM tie-ups

Key Aneroid Sphygmomanometers Companies18 items

A&D Medical

GE Healthcare

Omron

Philips

Microlife Corporation

Paul Hartmann AG

Suntech Medical

Welch Allyn

American Diagnostic

Beurer

Rudolf Riester GmbH

Terumo Corporation

Bosch + Sohn

Briggs Healthcare

Choicemmed

Citizen

W.A. Baum

Rossmax International

Market Ecosystem

The Aneroid Sphygmomanometers ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value creation and capture occur as raw materials and components are transformed into finished products, which are then distributed to end users through various channels. The Aneroid Sphygmomanometers ecosystem is characterized by a complex interplay of participants, each playing a distinct role in the value chain analysis.

Raw material/component suppliers — providing essential materials

OEMs / manufacturers — producing aneroid sphygmomanometers

Distributors / channel partners — delivering products to end users

Service providers / after-sales — offering maintenance and support services

End users / buyers — utilizing aneroid sphygmomanometers for healthcare purposes

Regulators/standards bodies — establishing guidelines and standards

Data/analytics providers — offering insights on market trends and performance

The flow of value in the Aneroid Sphygmomanometers ecosystem is influenced by control points, such as regulatory bodies and end-user preferences. Dependency risks, including input constraints and standards approvals, can impact the ecosystem's functioning. Moreover, switching costs, partnerships, and interoperability requirements can affect the relationships between participants. The ecosystem's dynamics can differ by region, with varying levels of adoption and market characteristics. Understanding these factors is crucial for navigating the complex Aneroid Sphygmomanometers ecosystem.

Recent Industry Insights

The Aneroid Sphygmomanometers industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between leading manufacturers and healthcare providers have focused on improving the accuracy and accessibility of aneroid sphygmomanometers. Notable mergers and acquisitions have also taken place, with companies like Omron and Hillrom expanding their product portfolios. Furthermore, innovative product launches, such as wireless and digital aneroid sphygmomanometers, have enhanced the market's growth prospects. Regulatory changes, including stricter guidelines for medical device manufacturing, have also influenced the industry. A shift in consumer trends towards home healthcare and preventive care has driven the demand for aneroid sphygmomanometers, with companies responding by launching user-friendly and affordable products.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Aneroid Sphygmomanometers market outlook. The market attractiveness is moderate, driven by the increasing demand for portable and accurate blood pressure monitoring devices. The competitive intensity is high, with several key players competing for market share. The long-term outlook is positive, with the market expected to grow due to the rising prevalence of hypertension and other cardiovascular diseases.

The innovation landscape is evolving, with a focus on digital and connected sphygmomanometers. The demand-supply balance is currently stable, but may shift in the future due to changes in regulatory requirements. Key risk factors include intense competition and fluctuating raw material prices. Overall, the Aneroid Sphygmomanometers market outlook is promising, with opportunities for growth and innovation in the coming years.

11 items

1. Executive Summary

2. Aneroid Sphygmomanometers Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Aneroid Sphygmomanometers Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Aneroid Sphygmomanometers Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Clinics

6.1.3. Household

6.2. Global Aneroid Sphygmomanometers Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Wrist

6.2.2. Arm Type

6.3. Global Aneroid Sphygmomanometers Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Aneroid Sphygmomanometers Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Aneroid Sphygmomanometers Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Aneroid Sphygmomanometers Market Competition by Key Manufacturers

8.1. Global Aneroid Sphygmomanometers Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Aneroid Sphygmomanometers: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. A&D Medical

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. GE Healthcare

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Omron

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Philips

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Microlife Corporation

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Paul Hartmann AG

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Suntech Medical

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Welch Allyn

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. American Diagnostic

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Beurer

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Rudolf Riester GmbH

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Terumo Corporation

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Bosch + Sohn

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Briggs Healthcare

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Choicemmed

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Citizen

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. W.A. Baum

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Rossmax International

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Aneroid Sphygmomanometers Market

Figure 4: Global Aneroid Sphygmomanometers Market: Drivers

Figure 5: Global Aneroid Sphygmomanometers Market: Challenges

Figure 6: Global Aneroid Sphygmomanometers Market: Trends

Figure 7: Global Aneroid Sphygmomanometers Market: Opportunity

Figure 8: Global Aneroid Sphygmomanometers Market: Restraint

Figure 9: Global Aneroid Sphygmomanometers Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Aneroid Sphygmomanometers Market Value (USD Million) By Region

Figure 15: Global Aneroid Sphygmomanometers Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Aneroid Sphygmomanometers Market Value (USD Million) By Region

Figure 23: Global Aneroid Sphygmomanometers Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

89 items

Table 1: Market Segmentation Analysis

Table 2: Global Aneroid Sphygmomanometers Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Aneroid Sphygmomanometers Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Aneroid Sphygmomanometers Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Aneroid Sphygmomanometers Market Value (USD Million) By Region

Table 10: Global Aneroid Sphygmomanometers Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Aneroid Sphygmomanometers Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Aneroid Sphygmomanometers Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Aneroid Sphygmomanometers Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: A&D Medical Basic Information And Sales Area

Table 31: A&D Medical. Products Portfolio

Table 32: GE Healthcare Basic Information And Sales Area

Table 33: GE Healthcare. Products Portfolio

Table 34: Omron Basic Information And Sales Area

Table 35: Omron. Products Portfolio

Table 36: Philips Basic Information And Sales Area

Table 37: Philips. Products Portfolio

Table 38: Microlife Corporation Basic Information And Sales Area

Table 39: Microlife Corporation. Products Portfolio

Table 40: Paul Hartmann AG Basic Information And Sales Area

Table 41: Paul Hartmann AG. Products Portfolio

Table 42: Suntech Medical Basic Information And Sales Area

Table 43: Suntech Medical. Products Portfolio

Table 44: Welch Allyn Basic Information And Sales Area

Table 45: Welch Allyn. Products Portfolio

Table 46: American Diagnostic Basic Information And Sales Area

Table 47: American Diagnostic. Products Portfolio

Table 48: Beurer Basic Information And Sales Area

Table 49: Beurer. Products Portfolio

Table 50: Rudolf Riester GmbH Basic Information And Sales Area

Table 51: Rudolf Riester GmbH. Products Portfolio

Table 52: Terumo Corporation Basic Information And Sales Area

Table 53: Terumo Corporation. Products Portfolio

Table 54: Bosch + Sohn Basic Information And Sales Area

Table 55: Bosch + Sohn. Products Portfolio

Table 56: Briggs Healthcare Basic Information And Sales Area

Table 57: Briggs Healthcare. Products Portfolio

Table 58: Choicemmed Basic Information And Sales Area

Table 59: Choicemmed. Products Portfolio

Table 60: Citizen Basic Information And Sales Area

Table 61: Citizen. Products Portfolio

Table 62: W.A. Baum Basic Information And Sales Area

Table 63: W.A. Baum. Products Portfolio

Table 64: Rossmax International Basic Information And Sales Area

Table 65: Rossmax International. Products Portfolio

Table 66: Global Market Value (USD Million) (2025-2032) By Application

Table 67: Global Market Share (%) By Application (2032)

Table 68: Global Market Value (USD Million) (2025-2032) By Types

Table 69: Global Market Share (%) By Types (2032)

Table 70: Global Aneroid Sphygmomanometers Market Value (USD Million) By Region

Table 71: Global Aneroid Sphygmomanometers Market Share (%) By Region (2025-2032)

Table 72: North America Market Value (USD Million) (2025-2032) By Country

Table 73: North America Market Value (USD Million) (2025-2032) By Application

Table 74: North America Market Value (USD Million) (2025-2032) By Types

Table 75: Europe Market Value (USD Million) (2025-2032) By Country

Table 76: Europe Market Value (USD Million) (2025-2032) By Application

Table 77: Europe Market Value (USD Million) (2025-2032) By Types

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 81: South America Market Value (USD Million) (2025-2032) By Country

Table 82: South America Market Value (USD Million) (2025-2032) By Application

Table 83: South America Market Value (USD Million) (2025-2032) By Types

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 87: Research Programs/Design For This Report

Table 88: Key Data Information From Secondary Sources

Table 89: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Aneroid Sphygmomanometers Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	7.14 billion
Revenue forecast in 2033	12.46 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	A&D Medical; GE Healthcare; Omron; Philips; Microlife Corporation; Paul Hartmann AG; Suntech Medical; Welch Allyn; American Diagnostic; Beurer; Rudolf Riester GmbH; Terumo Corporation; Bosch + Sohn; Briggs Healthcare; Choicemmed; Citizen; W.A. Baum; Rossmax International
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options